集泰股份(002909.SZ):3名董事、高管提前終止減持計劃 石正金累計減持10萬股
格隆匯5月20日丨集泰股份(002909.SZ)公佈,2020年5月20日,公司董事會收到公司董事及高級管理人員孫仲華、高級管理人員石正金和羅鴻橋出具的《關於減持所持廣州集泰化工股份有限公司股份的進展情況暨終止減持計劃告知函》。在減持計劃實施期內,石正金累計減持公司股份10萬股,佔目前公司總股本1.67億股的0.06%,其減持計劃已實施完成;孫仲華、羅鴻橋均未發生減持行為。前述三位股東決定提前終止實施此次減持計劃。
此次減持後,石正金持有股份32.07萬股,佔總股本比例0.19%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.